Food  ||| S:0 E:5 ||| NN
allergy ||| S:5 E:12 ||| NN
:  ||| S:12 E:14 ||| :
recent  ||| S:14 E:21 ||| JJ
advances  ||| S:21 E:30 ||| NNS
in  ||| S:30 E:33 ||| IN
pathophysiology  ||| S:33 E:49 ||| NN
and  ||| S:49 E:53 ||| CC
diagnosis  ||| S:53 E:63 ||| NN
Approximately  ||| S:63 E:77 ||| RB
5 ||| S:77 E:78 ||| CD
%  ||| S:78 E:80 ||| NN
of  ||| S:80 E:83 ||| IN
young  ||| S:83 E:89 ||| JJ
children  ||| S:89 E:98 ||| NNS
and  ||| S:98 E:102 ||| CC
3-4 ||| S:102 E:105 ||| CD
%  ||| S:105 E:107 ||| NN
of  ||| S:107 E:110 ||| IN
adults  ||| S:110 E:117 ||| NNS
exhibit  ||| S:117 E:125 ||| VBP
adverse  ||| S:125 E:133 ||| JJ
immune  ||| S:133 E:140 ||| JJ
responses  ||| S:140 E:150 ||| NNS
to  ||| S:150 E:153 ||| TO
foods  ||| S:153 E:159 ||| NNS
in  ||| S:159 E:162 ||| IN
westernized  ||| S:162 E:174 ||| JJ
countries ||| S:174 E:183 ||| NNS
,  ||| S:183 E:185 ||| ,
with  ||| S:185 E:190 ||| IN
a  ||| S:190 E:192 ||| DT
tendency  ||| S:192 E:201 ||| NN
to  ||| S:201 E:204 ||| TO
increase ||| S:204 E:212 ||| VB
.  ||| S:212 E:214 ||| .
The  ||| S:214 E:218 ||| DT
pathophysiology  ||| S:218 E:234 ||| NN
of  ||| S:234 E:237 ||| IN
food  ||| S:237 E:242 ||| NN
allergy  ||| S:242 E:250 ||| NN
( ||| S:250 E:251 ||| -LRB-
FA ||| S:251 E:253 ||| NNP
)  ||| S:253 E:255 ||| -RRB-
relies  ||| S:255 E:262 ||| VBZ
on  ||| S:262 E:265 ||| IN
immune  ||| S:265 E:272 ||| JJ
reactions  ||| S:272 E:282 ||| NNS
triggered  ||| S:282 E:292 ||| VBN
by  ||| S:292 E:295 ||| IN
epitopes ||| S:295 E:303 ||| NN
,  ||| S:303 E:305 ||| ,
i.e.  ||| S:305 E:310 ||| FW
small  ||| S:310 E:316 ||| JJ
amino-acid  ||| S:316 E:327 ||| JJ
sequences  ||| S:327 E:337 ||| JJ
able  ||| S:337 E:342 ||| JJ
to  ||| S:342 E:345 ||| TO
bind  ||| S:345 E:350 ||| VB
to  ||| S:350 E:353 ||| TO
antibodies  ||| S:353 E:364 ||| NNS
or  ||| S:364 E:367 ||| CC
cells ||| S:367 E:372 ||| NNS
.  ||| S:372 E:374 ||| .
Some  ||| S:374 E:379 ||| DT
food  ||| S:379 E:384 ||| NN
allergens  ||| S:384 E:394 ||| NN
share  ||| S:394 E:400 ||| NN
specific  ||| S:400 E:409 ||| JJ
physicochemical  ||| S:409 E:425 ||| JJ
characteristics  ||| S:425 E:441 ||| NNS
that  ||| S:441 E:446 ||| WDT
allow  ||| S:446 E:452 ||| VBP
them  ||| S:452 E:457 ||| PRP
to  ||| S:457 E:460 ||| TO
resist  ||| S:460 E:467 ||| VB
digestion ||| S:467 E:476 ||| NNS
,  ||| S:476 E:478 ||| ,
thus  ||| S:478 E:483 ||| RB
enhancing  ||| S:483 E:493 ||| VBG
allergenicity ||| S:493 E:506 ||| NNS
.  ||| S:506 E:508 ||| .
These  ||| S:508 E:514 ||| DT
allergens  ||| S:514 E:524 ||| JJ
encounter  ||| S:524 E:534 ||| NNS
specialized  ||| S:534 E:546 ||| VBN
dendritic  ||| S:546 E:556 ||| JJ
cell  ||| S:556 E:561 ||| NN
populations  ||| S:561 E:573 ||| NNS
in  ||| S:573 E:576 ||| IN
the  ||| S:576 E:580 ||| DT
gut ||| S:580 E:583 ||| NN
,  ||| S:583 E:585 ||| ,
which  ||| S:585 E:591 ||| WDT
leads  ||| S:591 E:597 ||| VBZ
to  ||| S:597 E:600 ||| TO
T-cell  ||| S:600 E:607 ||| JJ
priming ||| S:607 E:614 ||| NN
.  ||| S:614 E:616 ||| .
In  ||| S:616 E:619 ||| IN
case  ||| S:619 E:624 ||| NN
of  ||| S:624 E:627 ||| IN
IgE-mediated  ||| S:627 E:640 ||| JJ
allergy ||| S:640 E:647 ||| NN
,  ||| S:647 E:649 ||| ,
this  ||| S:649 E:654 ||| DT
process  ||| S:654 E:662 ||| NN
triggers  ||| S:662 E:671 ||| VBZ
the  ||| S:671 E:675 ||| DT
production  ||| S:675 E:686 ||| NN
of  ||| S:686 E:689 ||| IN
allergen-specific  ||| S:689 E:707 ||| JJ
IgE  ||| S:707 E:711 ||| NN
by  ||| S:711 E:714 ||| IN
B  ||| S:714 E:716 ||| NNP
cells ||| S:716 E:721 ||| NNS
.  ||| S:721 E:723 ||| .
Tissue-resident  ||| S:723 E:739 ||| JJ
reactive  ||| S:739 E:748 ||| JJ
cells ||| S:748 E:753 ||| NNS
,  ||| S:753 E:755 ||| ,
including  ||| S:755 E:765 ||| VBG
mast  ||| S:765 E:770 ||| JJ
cells ||| S:770 E:775 ||| NNS
,  ||| S:775 E:777 ||| ,
then  ||| S:777 E:782 ||| RB
bind  ||| S:782 E:787 ||| JJ
IgE ||| S:787 E:790 ||| NN
,  ||| S:790 E:792 ||| ,
and  ||| S:792 E:796 ||| CC
allergic  ||| S:796 E:805 ||| JJ
reactions  ||| S:805 E:815 ||| NNS
are  ||| S:815 E:819 ||| VBP
elicited  ||| S:819 E:828 ||| VBN
when  ||| S:828 E:833 ||| WRB
these  ||| S:833 E:839 ||| DT
cells ||| S:839 E:844 ||| NNS
,  ||| S:844 E:846 ||| ,
with  ||| S:846 E:851 ||| IN
adjacent  ||| S:851 E:860 ||| JJ
IgE  ||| S:860 E:864 ||| JJ
molecules  ||| S:864 E:874 ||| NNS
bound  ||| S:874 E:880 ||| VBN
to  ||| S:880 E:883 ||| TO
their  ||| S:883 E:889 ||| PRP$
surface ||| S:889 E:896 ||| NN
,  ||| S:896 E:898 ||| ,
are  ||| S:898 E:902 ||| VBP
re-exposed  ||| S:902 E:913 ||| JJ
to  ||| S:913 E:916 ||| TO
allergen ||| S:916 E:924 ||| VB
.  ||| S:924 E:926 ||| .
Allergic  ||| S:926 E:935 ||| JJ
reactions  ||| S:935 E:945 ||| NNS
occurring  ||| S:945 E:955 ||| VBG
in  ||| S:955 E:958 ||| IN
the  ||| S:958 E:962 ||| DT
absence  ||| S:962 E:970 ||| NN
of  ||| S:970 E:973 ||| IN
detectable  ||| S:973 E:984 ||| JJ
IgE  ||| S:984 E:988 ||| NNS
are  ||| S:988 E:992 ||| VBP
labeled  ||| S:992 E:1000 ||| VBN
non-IgE  ||| S:1000 E:1008 ||| JJ
mediated ||| S:1008 E:1016 ||| NN
.  ||| S:1016 E:1018 ||| .
The  ||| S:1018 E:1022 ||| DT
abrogation  ||| S:1022 E:1033 ||| NN
of  ||| S:1033 E:1036 ||| IN
oral  ||| S:1036 E:1041 ||| JJ
tolerance  ||| S:1041 E:1051 ||| NN
which  ||| S:1051 E:1057 ||| WDT
leads  ||| S:1057 E:1063 ||| VBZ
to  ||| S:1063 E:1066 ||| TO
FA  ||| S:1066 E:1069 ||| NNP
is  ||| S:1069 E:1072 ||| VBZ
likely  ||| S:1072 E:1079 ||| RB
favored  ||| S:1079 E:1087 ||| VBN
by  ||| S:1087 E:1090 ||| IN
genetic  ||| S:1090 E:1098 ||| JJ
disposition  ||| S:1098 E:1110 ||| NN
and  ||| S:1110 E:1114 ||| CC
environmental  ||| S:1114 E:1128 ||| JJ
factors  ||| S:1128 E:1136 ||| NNS
( ||| S:1136 E:1137 ||| -LRB-
e.g.  ||| S:1137 E:1142 ||| NNP
increased  ||| S:1142 E:1152 ||| VBD
hygiene  ||| S:1152 E:1160 ||| JJ
or  ||| S:1160 E:1163 ||| CC
enhanced  ||| S:1163 E:1172 ||| JJ
allergenicity  ||| S:1172 E:1186 ||| NN
of  ||| S:1186 E:1189 ||| IN
some  ||| S:1189 E:1194 ||| DT
foods ||| S:1194 E:1199 ||| NNS
) ||| S:1199 E:1200 ||| -RRB-
.  ||| S:1200 E:1202 ||| .
For  ||| S:1202 E:1206 ||| IN
an  ||| S:1206 E:1209 ||| DT
accurate  ||| S:1209 E:1218 ||| JJ
diagnosis ||| S:1218 E:1227 ||| NN
,  ||| S:1227 E:1229 ||| ,
complete  ||| S:1229 E:1238 ||| JJ
medical  ||| S:1238 E:1246 ||| JJ
history ||| S:1246 E:1253 ||| NN
,  ||| S:1253 E:1255 ||| ,
laboratory  ||| S:1255 E:1266 ||| NN
tests  ||| S:1266 E:1272 ||| NNS
and ||| S:1272 E:1275 ||| CC
,  ||| S:1275 E:1277 ||| ,
in  ||| S:1277 E:1280 ||| IN
most  ||| S:1280 E:1285 ||| JJS
cases ||| S:1285 E:1290 ||| NNS
,  ||| S:1290 E:1292 ||| ,
an  ||| S:1292 E:1295 ||| DT
oral  ||| S:1295 E:1300 ||| JJ
food  ||| S:1300 E:1305 ||| NN
challenge  ||| S:1305 E:1315 ||| NN
are  ||| S:1315 E:1319 ||| VBP
needed ||| S:1319 E:1325 ||| VBN
.  ||| S:1325 E:1327 ||| .
Noticeably ||| S:1327 E:1337 ||| RB
,  ||| S:1337 E:1339 ||| ,
the  ||| S:1339 E:1343 ||| DT
detection  ||| S:1343 E:1353 ||| NN
of  ||| S:1353 E:1356 ||| IN
food-specific  ||| S:1356 E:1370 ||| JJ
IgE  ||| S:1370 E:1374 ||| NN
( ||| S:1374 E:1375 ||| -LRB-
sensitization ||| S:1375 E:1388 ||| LS
)  ||| S:1388 E:1390 ||| -RRB-
does  ||| S:1390 E:1395 ||| VBZ
not  ||| S:1395 E:1399 ||| RB
necessarily  ||| S:1399 E:1411 ||| RB
indicate  ||| S:1411 E:1420 ||| VB
clinical  ||| S:1420 E:1429 ||| JJ
allergy ||| S:1429 E:1436 ||| NN
.  ||| S:1436 E:1438 ||| .
Novel  ||| S:1438 E:1444 ||| JJ
diagnostic  ||| S:1444 E:1455 ||| JJ
methods  ||| S:1455 E:1463 ||| NNS
currently  ||| S:1463 E:1473 ||| RB
under  ||| S:1473 E:1479 ||| IN
study  ||| S:1479 E:1485 ||| NN
focus  ||| S:1485 E:1491 ||| NN
on  ||| S:1491 E:1494 ||| IN
the  ||| S:1494 E:1498 ||| DT
immune  ||| S:1498 E:1505 ||| JJ
responses  ||| S:1505 E:1515 ||| NNS
to  ||| S:1515 E:1518 ||| TO
specific  ||| S:1518 E:1527 ||| JJ
food  ||| S:1527 E:1532 ||| NN
proteins  ||| S:1532 E:1541 ||| NNS
or  ||| S:1541 E:1544 ||| CC
epitopes  ||| S:1544 E:1553 ||| NN
of  ||| S:1553 E:1556 ||| IN
specific  ||| S:1556 E:1565 ||| JJ
proteins ||| S:1565 E:1573 ||| NNS
.  ||| S:1573 E:1575 ||| .
Food-induced  ||| S:1575 E:1588 ||| JJ
allergic  ||| S:1588 E:1597 ||| JJ
reactions  ||| S:1597 E:1607 ||| NNS
represent  ||| S:1607 E:1617 ||| VBP
a  ||| S:1617 E:1619 ||| DT
large  ||| S:1619 E:1625 ||| JJ
array  ||| S:1625 E:1631 ||| NN
of  ||| S:1631 E:1634 ||| IN
symptoms  ||| S:1634 E:1643 ||| NNS
involving  ||| S:1643 E:1653 ||| VBG
the  ||| S:1653 E:1657 ||| DT
skin  ||| S:1657 E:1662 ||| NN
and  ||| S:1662 E:1666 ||| CC
gastrointestinal  ||| S:1666 E:1683 ||| NNS
and  ||| S:1683 E:1687 ||| CC
respiratory  ||| S:1687 E:1699 ||| JJ
systems ||| S:1699 E:1706 ||| NNS
.  ||| S:1706 E:1708 ||| .
They  ||| S:1708 E:1713 ||| PRP
can  ||| S:1713 E:1717 ||| MD
be  ||| S:1717 E:1720 ||| VB
attributed  ||| S:1720 E:1731 ||| VBN
to  ||| S:1731 E:1734 ||| TO
IgE-mediated  ||| S:1734 E:1747 ||| JJ
and  ||| S:1747 E:1751 ||| CC
non-IgE-mediated  ||| S:1751 E:1768 ||| NNP
( ||| S:1768 E:1769 ||| -LRB-
cellular ||| S:1769 E:1777 ||| JJ
)  ||| S:1777 E:1779 ||| -RRB-
mechanisms  ||| S:1779 E:1790 ||| NNS
and  ||| S:1790 E:1794 ||| CC
thus  ||| S:1794 E:1799 ||| RB
differ  ||| S:1799 E:1806 ||| VB
in  ||| S:1806 E:1809 ||| IN
their  ||| S:1809 E:1815 ||| PRP$
nature ||| S:1815 E:1821 ||| NN
,  ||| S:1821 E:1823 ||| ,
severity  ||| S:1823 E:1832 ||| NN
and  ||| S:1832 E:1836 ||| CC
outcome ||| S:1836 E:1843 ||| NN
.  ||| S:1843 E:1845 ||| .
Outcome  ||| S:1845 E:1853 ||| NN
also  ||| S:1853 E:1858 ||| RB
differs  ||| S:1858 E:1866 ||| VBZ
according  ||| S:1866 E:1876 ||| VBG
to  ||| S:1876 E:1879 ||| TO
allergens ||| S:1879 E:1888 ||| VB
.  ||| S:1888 E:1890 ||| .
